// App-Quantinova.ai

3100 : Diamond and Forrester-predicted vs. coronary CTA-observed prevalence of obstructive CAD in patients with stable chest pain: results from the PROMISE trial

Researchers

Presenter

  • B Foldyna

Principal Investigators

  • J Karady

  • D Banerji

  • M T Lu

  • M Ferencik

  • T Mayrhofer

  • D O Bittner

  • J E Udelson

  • C B Fordyce

  • N Meyersohn

Medical Centers

  • Massachusetts General Hospital - Boston - United States of America

  • Oregon Health & Science University, Knight Cardiovascular Institute, Portland, United States of America

  • Stralsund University of Applied Sciences, School of Business Studies, Stralsund, Germany

  • Friedrich Alexander University, Department of Cardiology, Erlangen, Germany

  • Tufts University School of Medicine and the Cardiovascular Center, Tufts Medical Center, Boston, United States of America

  • University of British Columbia, Division of Gastroenterology, Vancouver, Canada

Locations

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • Regenerating islet-derived 1 alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • NCT01174550

Sponsors

  • National Heart Institute

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved